Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

13.06

+0.37 (2.92%)

Jan 21, 2025, 4:00 PM EST - Market closed

Entrada Therapeutics Employees

Entrada Therapeutics had 159 employees as of December 31, 2023. The number of employees increased by 29 or 22.31% compared to the previous year.

Employees

159

Change (1Y)

29

Growth (1Y)

22.31%

Revenue / Employee

$1,353,660

Profits / Employee

$345,604

Market Cap

462.39M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	159	29	22.31%
Dec 31, 2022	130	16	14.04%
Dec 31, 2021	114	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	440,000
Johnson & Johnson	131,900
Thermo Fisher Scientific	122,000
Abbott Laboratories	114,000
AstraZeneca	89,900
Novartis AG	76,057
Merck & Co.	72,000
Novo Nordisk	64,319

Employee Rankings

TRDA News

4 weeks ago - Entrada Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
3 months ago - Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society - GlobeNewsWire
4 months ago - Entrada Therapeutics Promotes Natarajan Sethuraman, PhD, to President of Research and Development - GlobeNewsWire
4 months ago - āshibio Announces Appointment of Dipal Doshi, CEO of Entrada Therapeutics, to its Board of Directors - Business Wire
4 months ago - Entrada Therapeutics Announces Recipients of Second Annual Diversity, Representation, Equity and Advocacy MatterS (DREAMS) Grant Program - GlobeNewsWire
7 months ago - Entrada Therapeutics Announces $100 Million Registered Direct Offering - GlobeNewsWire
7 months ago - Entrada Therapeutics Reports Positive Preliminary Data in Healthy Volunteers from Phase 1 ENTR-601-44-101 Trial for Duchenne Muscular Dystrophy - GlobeNewsWire
8 months ago - Entrada Therapeutics to Present at Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire